FDA recall D-1361-2019

Torrent Pharma Inc · Class II · drug

Product

Cetirizine HCL Oral Solution, USP 1mg/mL, 4 oz - BULK, PLD

Reason for recall

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Distribution

Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.

Key facts

Status
Terminated
Initiation date
2019-05-21
Report date
2019-06-19
Termination date
2020-10-06
Voluntary/Mandated
Voluntary: Firm initiated
Location
Levittown, PA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1361-2019